People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology, Other Technology, Tourism and Travel Services, Retailing, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Scorpion Therapeutics, Inc. | — | Biotechnology | Series D+ | $297.4M | $1.4B | 2024 |
| Antares Therapeutics, Inc. | — | Biotechnology | Series B | $70.0M | $149.6M | 2025 |
| Mojito Inc. | — | Other Technology | Series B | $20.0M | $380.1M | 2021 |
| Monaker Group, Inc. | — | Tourism and Travel Services | Seed | $8.2M | $22.0M | 2015 |
| MYMO Inc. | — | Retailing | Series A | $6.7M | $25.0M | 2022 |
| Verus International, Inc. | — | Other | Seed | $6.6M | $9.3M | 2013 |
Adam Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jean-Francois Formela | 2 | 17 |
| Shelley Chu | 2 | 10 |
| Keith Flaherty | 2 | 5 |
| Pat LaVecchia | 2 | 3 |
| William Kerby | 2 | 3 |
| Jeffrey Albers | 2 | 3 |
| Brian Piper | 2 | 2 |
| Andrew Fedder | 2 | 2 |
| Gary Glick | 1 | 7 |
| Arjun Goyal | 1 | 5 |
| Otello Stampacchia | 1 | 4 |
| Steven Sjoblad | 1 | 3 |
| Oleg Nodelman | 1 | 3 |
| Donald P. Monaco | 1 | 2 |
| Keith White | 1 | 2 |
| Michael O'Gorman | 1 | 2 |
| Christopher Larson | 1 | 2 |
| Donald Monaco | 1 | 2 |
| Mark S. Lemon | 1 | 1 |
| Robert Lumpkins | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.